Chen Wei-Qiang

Prof. Chen Wei-Qiang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
YHYanfang Huang
Yanfang Huang
SLSijia Li
Sijia Li
XLXiuli Lu
Xiuli Lu
CWChen Wei-Qiang
Chen Wei-Qiang
YZYun Zhang
Yun Zhang
Background: Chronic diseases significantly impact global morbidity and mortality, affecting millions. Self-management interventions are crucial for improving patient health outcomes. This study explores the effects of self-management interventions on the quality of life (QOL), self-efficacy, depression, and anxiety of patients with chronic diseases. Methods: Relevant studies were searched from PubMed, EMBASE, and Web of Science. Two reviewers independently screened the literature, evaluated the risk of bias assessment, and extracted characteristics and outcomes among patients with chronic diseases. For each included study, we calculated the standardized mean difference (SMD) and 95% confidence interval (CI) of the main outcomes. When deemed feasible, the heterogeneity of the study was explored by meta-analysis and subgroup analysis. Results: Thirty-four studies involving a total of 7603 patients with chronic diseases were included. Self-management interventions significantly improved quality of life (Higher-better QOL and Lower-better QOL), self-efficacy, and reduced depression symptoms compared to usual care (95%CI 0.01 to 0.15, p = 0.03; 95%CI −0.49 to −0.08, p = 0.006; 95%CI 0.19 to 0.62, p < 0.001; 95%CI −0.23 to −0.07, p < 0.001). However, no significant effect was found for anxiety (95%CI −0.18 to 0.03, p = 0.18). In the heterogeneity analysis, Lower-better QOL and self-efficacy were all higher than 50% (I2 = 80%, 87%). After the subgroup analysis, the heterogeneity of Lower-better QOL and self-efficacy was less than 50% (I2 = 0%, 16.1%). Subgroup analyses revealed that studies with mean age greater than 60 years old and follow-up times greater than 6 months were more effective in improving patients’ Lower-better QOL (p = 0.03, p = 0.004), whereas follow-up times less than 6 months were better at reducing patients’ anxiety symptoms (p = 0.03). Conclusions: Self-management interventions are more effective than routine care in managing chronic diseases, significantly improving patients’ quality of life, self-efficacy, and reducing depressive symptoms, but they did not show significant improvements in anxiety symptoms. Overall, self-management interventions for chronic diseases can help patients adapt to the changes brought about by the disease and self-manage diseases to prevent disease progression.

11 December 2018 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
QXQiuxiang Xu
Qiuxiang Xu
MLMing Li
Ming Li
MYMengdie Yang
Mengdie Yang
JYJiebo Yang
Jiebo Yang
JXJingjing Xie
Jingjing Xie
CWChen Wei-Qiang
Chen Wei-Qiang
The naturally occurring compound α-pinene induces cell cycle arrest and antitumor activity. We examined effects of α-pinene on cell cycle regulation in hepatocellular carcinoma cells (HepG2) cells to establish a foundation for its development as a novel treatment for hepatocellular carcinoma (HCC). HepG2 cells treated with α-pinene exhibited dose-dependent growth inhibition as a result of G2/M-phase cell cycle arrest. Cell cycle arrest was associated with down-regulated cyclin-dependent kinase 1 (CDK1) and miR-221 levels and up-regulated levels of CDKN1B/p27, γ-H2AX, phosphorylated ATM, phosphorylated Chk2 and phosphorylated p53. Our observations are consistent with a model in which α-pinene inhibits miR221 expression, which leads to G2/M-phase arrest and activation of CDKN1B/p27-CDK1 and ATM-p53-Chk2 pathways that suppress human hepatoma tumor progression. Additionally, α-pinene was found to trigger oxidative stress and induce apoptosis of HepG2 cells. α-pinene, therefore, represents a potential chemotherapeutic compound for the treatment of HCC.

8 September 2022 in Drug Development Research
Verified
Journal Article
Closed access
XHXiaosu Huang
Xiaosu Huang
PYPei Yan
Pei Yan
WDWenqing Ding
Wenqing Ding
CZChang Zhou
Chang Zhou
QXQiuxiang Xu
Qiuxiang Xu
CWChen Wei-Qiang
Chen Wei-Qiang

3 December 2019 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
LYLianbao Ye
Lianbao Ye
XZXiaoshun Zhang
Xiaoshun Zhang
QXQiuxiang Xu
Qiuxiang Xu
YCYongming Cai
Yongming Cai
WGWei Gao
Wei Gao
CWChen Wei-Qiang
Chen Wei-Qiang

Verified
Journal Article
Open access
PDF file
XHXiaosu Huang
Xiaosu Huang
JYJunhua Yang
Junhua Yang
RZRenyue Zhang
Renyue Zhang
LYLianbao Ye
Lianbao Ye
MLMing Li
Ming Li
CWChen Wei-Qiang
Chen Wei-Qiang
Globally, wound infection is considered to be one of the major healthcare problems, with bacterial infections being the most critical threat, leading to poor and delayed wound healing, and even death. As a superbug, methicillin-resistant Staphylococcus aureus (MRSA) causes a profound hazard to public health safety, prompting us to search for alternative treatment approaches. Herein, the MTT test and Hoechst/propidium iodide (PI) staining demonstrated that PD was slightly less toxic to human fibroblasts including Human keratinocytes (HaCaT) cell line than Silver sulfadiazine (SSD), and Vancomycin (Van). In the MRSA-infected wound model, PD hydrogel (1%, 2.5%) was applied with for 14 days. The wound healing of PD hydrogel groups was superior to the SSD, Van, and control groups. Remarkably, the experimental results showed that PD reduced the number of skin bacteria, reduced inflammation, and upregulated the expression of PCNA (keratinocyte proliferation marker) and CD31 (angiogenesis manufacturer) at the wound site by histology (including hematoxylin–eosin (HE) staining, Masson staining) and immunohistochemistry. Additionally, no toxicity, hemocompatibility or histopathological changes to organs were observed. Altogether, these results suggested the potential of PD hydrogel as a safe, effective, and low toxicity hydrogel for the future clinical treatment of MRSA-infected wounds.

27 November 2024 in BMC Nursing
Verified
Journal Article
Open access
PDF file
YZYun Zhang
Yun Zhang
SLSijia Li
Sijia Li
YHYanfang Huang
Yanfang Huang
CSCongjing Song
Congjing Song
JLJiale Li
Jiale Li
YYYiling Yang
Yiling Yang
In nursing practice, a high level of ethical sensitivity and humanistic care ability must always be maintained. A limited number of studies have investigated the correlation between the level of ethical sensitivity and humanistic care ability of nursing students. A survey study was conducted from November 2023 to January 2024 among 656 undergraduate nursing students using the General Information Questionnaire, Ethical Sensitivity Questionnaire For Nursing Students, and Humanistic Care Ability Inventory. The total ethical sensitivity score of nursing students (36.01 ± 6.31) was positively correlated with the total humanistic care ability score (r = 0.426, P < 0.01), and the results of the multivariate linear regression analysis showed that grade, relationship with parents, liking of the nursing major, willingness to work in nursing, experiences in learning nursing ethics, experience of caring for patients, and humanistic care ability are the main influencing factors of nursing students’ ethical sensitivity. The ethical sensitivity of undergraduate nursing students is at a moderate level, which shows a moderate and significant correlation with their humanistic care ability. College nursing educators and administrators should focus on integrating humanistic care ability education while increasing ethical education to cultivate excellent nursing students with comprehensive abilities.